The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
December 8th 2024
A propensity score-matched study from ASH 2024 suggests GLP-1 RA use reduced VTE risk in type 2 diabetes.
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
LARIAT Technique for Atrial Fibrillation Reduces Stroke Risk
Minimally invasive surgical technique for patients with atrial fibrillation who cannot tolerate standard anticoagulant therapy uses sutures to tie off the left atrial appendage and offers increased stroke protection.
Study Examines Heart Failure Care Protocol
March 7th 2014Stressing the significant effect heart failure has on quality of life, a study published in Heart found that patients' and their families' lack of knowledge on their condition causes delays in seeking medical attention and an absence of a long-term care plan.
FDA Approves Ablation Catheter for Atrial Fibrillation
The US Food and Drug Administration (FDA) has approved a new ablation catheter billed by its maker as the first such device on the U.S. market "that enables direct and real-time measurement of contact force" during procedures.
New Cholesterol Treatment Guideline: A Q&A With Thomas Dayspring, MD, FACP, FNLA, NCMP
March 5th 2014Thomas Dayspring, MD, FACP, FNLA, NCMP, discusses the promises and pitfalls of the 2013 American College of Cardiology/American Heart Association Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.
More on Catheter Ablation As First-line Therapy for Atrial Fibrillation
Study finds a lower rate of recurrent atrial tachyarrhythmias among patients with paroxysmal atrial fibrillation who underwent radiofrequency catheter ablation as a first-line treatment rather than taking antiarrhythmic drugs.
Alzheimer's Agitation Eased by Citalopram, But With Severe Adverse Effects
In a recent clinical trial, Celexa (citalopram) reduced agitation in patients with probable Alzheimer's disease (AD) compared to placebo, but the drug also produced severe cognitive and cardiac adverse events that prescribers must consider.
Pre-Op Intra-Aortic Balloon Pumps Improve Coronary Artery Bypass Grafting Results
February 25th 2014Though most studies on the preoperative use of intra-aortic balloon pumps in coronary artery bypass grafting patients have reported early results, they have not been able to determine long-term outcomes.
Hospitals With Pricing Power Don't Necessarily Provide High-Quality Care
February 20th 2014Among hospitals with solid income streams, one might expect the quality of care to be high. However, postsurgical mortality rates and patient-safety indicators showed high-price hospitals perform worse on inpatient care quality than low-price facilities.
FDA Panel Votes Against Naproxen's Cardiovascular Safety Claim
A US Food and Drug Administration (FDA) advisory panel has not found enough clinical evidence to conclude that naproxen presents a lower risk of cardiovascular (CV) thrombotic events than other nonsteroidal anti-inflammatory drugs (NSAIDs).
In Patients Hospitalized for Heart Failure, Hyponatremia Predicts Complications, But Not Mortality
February 18th 2014In a real-world sample of patients hospitalized for heart failure (HF), hyponatremia predicted clinical complications during admission, but it was not linked to short-term mortality or readmission.